DOCUMENT RESOURCES FOR EVERYONE
Documents tagged
A phase I study of CHR-2797, an orally active aminopeptidase inhibitor, in elderly and/or treatment refractory patients with acute myeloid leukemia or.
Documents A phase I study of CHR-2797, an orally active aminopeptidase inhibitor, in elderly and/or treatment....

Slide 1A phase I study of CHR-2797, an orally active aminopeptidase inhibitor, in elderly and/or treatment refractory patients with acute myeloid leukemia or multiple myeloma…

Every Week Counts Lisa M. Hollier, MD, MPH, FACOG Chair, District XI American Congress of Obstetricians and Gynecologists.
Documents Every Week Counts Lisa M. Hollier, MD, MPH, FACOG Chair, District XI American Congress of...

Slide 1Every Week Counts Lisa M. Hollier, MD, MPH, FACOG Chair, District XI American Congress of Obstetricians and Gynecologists Slide 2 Objectives At the completion of this…

Derivation and Validation of a Prediction Tool for Venous Thromboembolism (VTE): A VERITY Registry Study Roopen Arya, Shankaranarayana Paneesha, Aidan.
Documents Derivation and Validation of a Prediction Tool for Venous Thromboembolism (VTE): A VERITY Registry.....

Slide 1 Derivation and Validation of a Prediction Tool for Venous Thromboembolism (VTE): A VERITY Registry Study Roopen Arya, Shankaranarayana Paneesha, Aidan McManus, Nick…

Sponsored by the Clinical and Translational Science Institute and the Department of Population Health Division of Biostatistics Concepts on the Way from.
Documents Sponsored by the Clinical and Translational Science Institute and the Department of Population...

Slide 1 Sponsored by the Clinical and Translational Science Institute and the Department of Population Health Division of Biostatistics Concepts on the Way from Data to Decisions…

The Medicare Oncology Care Model – What It Is and What It Means for Practice April 9, 2015.
Documents The Medicare Oncology Care Model – What It Is and What It Means for Practice April 9, 2015.

Slide 1 The Medicare Oncology Care Model – What It Is and What It Means for Practice April 9, 2015 Slide 2 Moderator: Steve Allen, MD Professor of Medicine, Hofstra North…

Evaluating the Performance of a Previously Reported Risk Score to Predict Venous Thromboembolism: A VERITY Registry Study Denise O'Shaughnessy, Peter Rose,
Documents Evaluating the Performance of a Previously Reported Risk Score to Predict Venous Thromboembolism: A....

Slide 1 Evaluating the Performance of a Previously Reported Risk Score to Predict Venous Thromboembolism: A VERITY Registry Study Denise O'Shaughnessy, Peter Rose, Fran…

LATEST CONCEPTS IN LARGE CELL AND HODGKIN LYMPHOMAS Morton Coleman, M.D. Director, Center for Lymphoma and Myeloma New York-Presbyterian Hospital Weill.
Documents LATEST CONCEPTS IN LARGE CELL AND HODGKIN LYMPHOMAS Morton Coleman, M.D. Director, Center for...

LATEST CONCEPTS IN LARGE CELL AND HODGKIN LYMPHOMAS Morton Coleman, M.D. Director, Center for Lymphoma and Myeloma New York-Presbyterian Hospital Weill Cornell Medical Center…

RARE GERMLINE VARIABILITY IN PEDIATRIC LEUKEMIA. Cancer Biology Series January 29, 2013 Todd Druley, MD, PhD Assistant Professor of Pediatric and Genetics.
Documents RARE GERMLINE VARIABILITY IN PEDIATRIC LEUKEMIA. Cancer Biology Series January 29, 2013 Todd Druley,...

RARE GERMLINE VARIABILITY IN PEDIATRIC LEUKEMIA. Cancer Biology Series January 29, 2013 Todd Druley, MD, PhD Assistant Professor of Pediatric and Genetics Presenter Disclosure…

Popular Categories
Relevant Tags